BridgeBio Oncology Therapeutics (BBOT) EPS (Basic) (2024 - 2026)
BridgeBio Oncology Therapeutics (BBOT) posted EPS (Basic) of -$775.78 for Q1 2026, down 27936.3% sequentially from -$2.77 in Q4 2025, and down 3741806.33% YoY from N/an in Q1 2025.
BridgeBio Oncology Therapeutics (BBOT) EPS (Basic) (2024 - 2026) Analysis & Trends
BridgeBio Oncology Therapeutics has reported EPS (Basic) for 3 years, with the latest figure at -$775.78 in Q1 2026.
- Quarterly EPS (Basic) fell 3741806.33% year-over-year to -$775.78 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2912.7 (down 11196554.95% YoY) and the FY2025 annual result came in at -$7.48, down 7754.68% from the prior year.
- EPS (Basic) declined to -$775.78 in Q1 2026 per BBOT's latest filing, from -$2.77 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.1 in Q3 2024 and troughed at -$775.78 in Q1 2026.
- A 3-year average of -$86.71 and a median of -$0.02 in 2025 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2025 and 2026: EPS (Basic) tumbled 89.9% in 2025, then plunged 3741806.33% in 2026.
- Over 3 years, EPS (Basic) stood at -$0.17 in 2024, then sank by 1560.32% to -$2.77 in 2025, then plunged by 27936.3% to -$775.78 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$775.78, -$2.77, and -$1.95 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | BridgeBio Oncology Therapeutics | 726.38 Mn | 500.67 Mn | - | -0.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.88 |
| Mar 31, 2026 | -775.78 |
| Dec 31, 2025 | -2.77 |
| Sep 30, 2025 | -1.95 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | -0.02 |
| Dec 31, 2024 | -0.17 |
| Sep 30, 2024 | 0.10 |
| Jun 30, 2024 | 0.09 |
| Mar 31, 2024 | 0.08 |